Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells

MD Castellone, A Celetti, V Guarino, AM Cirafici… - Oncogene, 2004 - nature.com
MD Castellone, A Celetti, V Guarino, AM Cirafici, F Basolo, R Giannini, E Medico
Oncogene, 2004nature.com
Papillary thyroid carcinomas are characterized by rearrangements of the RET receptor
tyrosine kinase generating RET/PTC oncogenes. Here we show that osteopontin (OPN), a
secreted glycoprotein, is a major RET/PTC-induced transcriptional target in PC Cl 3 thyroid
follicular cells. OPN upregulation depended on the integrity of the RET/PTC kinase and
tyrosines Y1015 and Y1062, two major RET/PTC autophosphorylation sites. RET/PTC also
induced a strong overexpression of CD44, a cell surface signalling receptor for OPN …
Abstract
Papillary thyroid carcinomas are characterized by rearrangements of the RET receptor tyrosine kinase generating RET/PTC oncogenes. Here we show that osteopontin (OPN), a secreted glycoprotein, is a major RET/PTC-induced transcriptional target in PC Cl 3 thyroid follicular cells. OPN upregulation depended on the integrity of the RET/PTC kinase and tyrosines Y1015 and Y1062, two major RET/PTC autophosphorylation sites. RET/PTC also induced a strong overexpression of CD44, a cell surface signalling receptor for OPN. Upregulation of CD44 was dependent on RET/PTC Y1062, as well. Constitutive OPN overexpression or treatment with exogenous recombinant OPN sharply increased proliferation, Matrigel invasion and spreading in collagen gels of RET/PTC-transformed PC Cl 3 cells. These effects were impaired by the treatment of PC Cl 3-RET/PTC cells with OPN-and CD44-locking antibodies. Thus, RET/PTC signalling triggers an autocrine loop involving OPN and CD44 that sustains proliferation and invasion of transfomed PC Cl 3 thyrocytes.
nature.com